There has been another diabetes treatment-seeker that has filed to come public. Sirtris Pharmaceuticals has filed for an IPO and it has enlisted JPMorgan, CIBC, Piper Jaffray, JMP Securities, and Rodman & Renshaw as…
By William Trent, CFA of Stock Market Beat Large Cap Watch List member Barr Pharmaceuticals (BRL) reported a GAAP Loss: For the three months ended December 31, 2006, the Company recorded a loss of…
From BioHealth Investor Biotechnology PIPEX PHARMACEUTICAL +12.90% BOSTON LIFE SCIENCES +10.63% INSMED INC +7.58% CURAGEN CORP +7.25% IDM PHARMA INC +6.37% Diagnostic Substances GENELABS TECH INC +18.18% ICAGEN, INC. +14.15% EPICEPT CORPORATION +11.94% NYMOX…
A Canadian biotech company named Endoceutics, Inc. has filed with the SEC to raise up to $75 million via an IPO. The underwriting group is listed as First Albany, Oppenheimer, and Stifel Nicolaus. Endoceutics…
From BioHealth Investor Biotechnology CURAGEN CORP +12.36% REPLIDYNE, INC. +5.98% INSMED INC +4.76% LPATH INC +3.85% POLYDEX PHARM LTD +3.31% Diagnostic Substances GENELABS TECH INC +0.57% AVIGEN INC +0.29% Drug Delivery All stocks were…
by Aaron F. Barkoff We reported last month on a new declaratory judgment action that Apotex filed against GlaxoSmithKline (GSK) in the Eastern District of Virginia. In its complaint, Apotex alleged that Glaxo’s listing…
From BioHealth Investor On the front page of the Tuesday edition of Investors Business Daily, Reinhardt Krause wrote a great article on the expansion of the biotechnology boom around the U.S. California and Boston,…
From BioHealth Investor Biotechnology ORAGENICS INC +12.51% GTX, INC. +8.83% XTL BIOPHARMACEUTICA +7.83% CRITICAL THERAPEUTIC +7.27% OMRIX BIOPHARMACEUTI +6.77% Diagnostic Substances HEALTHCARE TECH LTD +9.16% OSTEOLOGIX INC +6.84% AVANT IMMUNOTHERAP +4.73% SYNOVICS PHARMACEUTL +4.00%…
Biotech Implosion: Threshold Pharmaceuticals (THLD) Threshold Pharmaceuticals, Inc. (THLD-NASDAQ) came clean after the close and announced that a Phase 3 trial of glufosfamide did not show a statistically significant improvement in overall survival in…
Boston Scientific (BSX) investors cringe every time a new study comes on about the long-term health hazards of stents. The drum beat has helped drop the share price from over $33 two years ago…
From BioHealth Investor Biotechnology NEOPHARM INC +29.21% CERAGENIX PHARMACUTL +11.11% AURIGA LABORATORIES +10.34% POLYMEDIX INC +7.69% PANACOS PHARMA INC +7.28% Diagnostic Substances ASPENBIO PHARMA INC +11.78% GENELABS TECH INC +7.98% EPIX PHARMACEUTICALS +6.79% AMER…
From BioHealth Investor The following articles were the most popular at BioHealth Investor for the week of February 17 – February 23. 1. Novadel Drops After Zensana Launch Delayed by Hana Biosciences 2. Acorda…
From BioHealth Investor Biotechnology PIPEX PHARMACEUTICAL +21.70% BIODELIVERY SCI INTL +21.37% AURIGA LABORATORIES +20.83% BIONOVO INC +10.73% BIOSANTE PHARMA INC +10.05% Diagnostic Substances ASPENBIO PHARMA INC +12.62% LEXICON GENETICS I +11.05% ICAGEN, INC. +7.31%…
From BioHealth Investor by Adam Rubenstein Colorado State University announced MicroRx, an entity designed to ally academia and commercial enterprise to ultimately accelerate the bench-to-bedside process. Infectious Disease is the focus of this first…
(AAPL) Apple & Cisco settled their iPhone trademark issue.(ADI) Analog Devices traded up 4% after beating estimates and signaling strengthening orders.(AMR) American Airlines raises its NYC-based flights after the JetBlue problems.(BEAS) BEA Systems reports…